Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience
| Autor: | Luca Bertolaccini, Andrea Viti, Alberto Gorla, A. Terzi |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Male medicine.medical_specialty Pleural effusion medicine.medical_treatment Thoracentesis Malignancy Catheters Indwelling medicine Malignant pleural effusion Humans Respiratory system Pleurodesis Aged Retrospective Studies Aged 80 and over business.industry Retrospective cohort study General Medicine Middle Aged medicine.disease Home Care Services Surgery Pleural Effusion Malignant Survival Rate Treatment Outcome Oncology Effusion Italy Drainage Female business Follow-Up Studies |
| Zdroj: | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 38(12) |
| ISSN: | 1532-2157 |
| Popis: | Background More than one half of patients with cancer have a malignant pleural effusion (MPE) at some time during their life span. Recurrent malignant pleural effusions impair respiratory functions and worsen the quality of life. Once a patient develops MPE, only fluid drainage relieves pulmonary compression and dyspnea. Optimal treatment is however, still controversial. In patients not suitable for pleurodesis, or with recurrent MPE after pleurodesis, or with trapped lung, the outpatient intermittent drainage through a subcutaneous tunneled indwelling pleural catheter (IPC) is a possible choice. Methods In ten years, we treated 90 patients by outpatient insertion of IPC. Eligibility for IPC required previous thoracentesis with histological confirmation of malignancy and chest roentgenogram evidence of effusion. All patients treated were made aware of their malignancy and positive cytology in the pleural effusion. Results Mean survival was 197 days (range 23–296 days). Median time of draining interval was 7.0 days with maximum amount of effusion drained off being 1000 ml. Pleurodesis occurred in 37 (41.1%) patients with a mean time of pleurodesis of 51 days (range 34–78 days). No major complication was recorded. Conclusions The IPC is a useful device in the management of recurrent MPE. Treatment can be entirely accomplished at home and the complication rate is low. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect